Assignee
PRAXIS PREC MEDICINES INC
US·32 granted patents·49 pending applications·83 citations·filing 2017–2025
Top patents by PatentIndex Score
81 records- 0198US11279700B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Mar 22, 2022·13 cites·20 claims
- 0298US11014931B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2020·Granted May 25, 2021·18 cites·18 claims
- 0395US11773088B2KCNT1 inhibitors and methods of usePRAXIS PREC MEDICINES INC·Filed 2021·Granted Oct 3, 2023·3 cites·19 claims
- 0495US11731978B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2022·Granted Aug 22, 2023·2 cites·4 claims
- 0595US11261188B2Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channelPRAXIS PREC MEDICINES INC·Filed 2017·Granted Mar 1, 2022·11 cites·16 claims
- 0693US11767325B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Sep 26, 2023·3 cites·16 claims
- 0793US11731976B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2021·Granted Aug 22, 2023·2 cites·30 claims
- 0892US11278535B2Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2018·Granted Mar 22, 2022·11 cites·12 claims
- 0992US10562930B1Salts and crystal forms of GABAA positive allosteric modulatorPRAXIS PREC MEDICINES INC·Filed 2019·Granted Feb 18, 2020·5 cites·20 claims
- 1091US11427540B2Formulations of T-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2021·Granted Aug 30, 2022·4 cites·9 claims
- 1189US12077502B2Formulations of T-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2022·Granted Sep 3, 2024·2 cites·35 claims
- 1286US12325711B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2023·Granted Jun 10, 2025·0 cites·32 claims
- 1384US12404297B2Salts and crystal forms of GABA-A positive allosteric modulatorPRAXIS PREC MEDICINES INC·Filed 2023·Granted Sep 2, 2025·0 cites·17 claims
- 1483US11629146B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activityPRAXIS PREC MEDICINES INC·Filed 2017·Granted Apr 18, 2023·3 cites·14 claims
- 1583US11505554B2Substituted pyridines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Nov 22, 2022·1 cites·26 claims
- 1683US2025376475A1Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 1782US11697669B2Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereofPRAXIS PREC MEDICINES INC·Filed 2022·Granted Jul 11, 2023·1 cites·28 claims
- 1881US2025129066A1Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 1980US10927141B2Salts and crystal forms of GABAA positive allosteric modulatorPRAXIS PREC MEDICINES INC·Filed 2019·Granted Feb 23, 2021·2 cites·34 claims
- 2080US2024417375A1Formulations of t-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 2179US11649207B2Formulations of T-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2021·Granted May 16, 2023·1 cites·11 claims
- 2279US2025163068A1Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 2378US12145939B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2023·Granted Nov 19, 2024·0 cites·19 claims
- 2478US11866439B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2019·Granted Jan 9, 2024·1 cites·14 claims
- 2577US2023322790A1Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
- 2677US2025145629A1Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 2776US12030881B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2022·Granted Jul 9, 2024·0 cites·21 claims
- 2873US2025092405A1Methods of treatment of scn2a-related disordersPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 2972US12344615B2Substituted pyridines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2022·Granted Jul 1, 2025·0 cites·12 claims
- 3070US2023219938A1Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2022·Application pending·0 cites
- 3169US11918571B2Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2022·Granted Mar 5, 2024·0 cites·19 claims
- 3267US2022024967A1Salts and crystal forms of gaba-a positive allosteric modulatorPRAXIS PREC MEDICINES INC·Filed 2021·Application pending·0 cites
- 3367US2024190910A1Hemi-citrate salts of gaba-a positive allosteric modulator and crystalline form thereofPRAXIS PREC MEDICINES INC·Filed 2022·Application pending·0 cites
- 3466US12528772B2Formulations of T-type calcium channel modulators and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2020·Granted Jan 20, 2026·0 cites·28 claims
- 3565US2023134428A1Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channelPRAXIS PREC MEDICINES INC·Filed 2022·Application pending·0 cites
- 3664US12259378B2Dynamic clamps and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2019·Granted Mar 25, 2025·0 cites·7 claims
- 3764US2025146073A1Methods for the treatment of scn2a-related disordersPRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
- 3863US12582652B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2024·Granted Mar 24, 2026·0 cites·28 claims
- 3963US2025179503A1Methods of using oligomeric compounds to treat scn2a-related disordersPRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
- 4063US2026092037A1Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 4162US2026092036A1Crystalline salts of a t-type calcium channel modulator and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 4260US2024368142A1Kcnt1 inhibitors and methods of usePRAXIS PREC MEDICINES INC·Filed 2022·Application pending·0 cites
- 4359US2025041284A1Treatment of neurological disordersPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 4459US2025295646A1Methods of use of t-type calcium channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
- 4559US2025170114A1Methods of treatment using t-type calcium channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
- 4659US2025375380A1High strength single unit dose formulations and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 4759US2025389712A1Dynamic clamps and methods of use thereofPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 4858US12583849B2KCNT1 inhibitors and methods of usePRAXIS PREC MEDICINES INC·Filed 2021·Granted Mar 24, 2026·0 cites·14 claims
- 4958US11492345B2Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2018·Granted Nov 8, 2022·0 cites·24 claims
- 5058US2025346576A1Kcnt1 inhibitors comprising a pyrazole core and methods of usePRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PRAXIS PREC MEDICINES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →